Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
D
Details...
Enter Symbol
Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN)
Sector: Medical
Current Price :
$6.32
52 Week Low
$5.86
52 Week High
$11.81
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
48M
Market Cap:
$0.29B
Avg Volume:
178774
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
On Fourth Quarter 13Fs
Mar 01, 2012 10:44 AM |
AAPL
,
ACFC
,
AMED
,
AMR
,
AMZN
,
ARII
Tickers For The Current Reshaping
Jan 05, 2011 10:06 AM |
AAPL
,
ABAX
,
ABC
,
ABT
,
ACAT
,
AEIS
Trading Plan For August 10, 2010
Aug 10, 2010 10:27 AM |
ENZN
,
INTC
,
V
How Will Obama-Care Play Into The Markets And ETFs?
Mar 22, 2010 01:27 AM |
ABT
,
ACOR
,
ADLR
,
AET
,
AFFX
,
AGN
15 Breakout Stocks On Huge Volume
Oct 08, 2009 09:51 AM |
AVNR
,
BRCD
,
CGR
,
ENZN
,
GIII
,
ICTG
More Articles on ENZN..
Market News
Enzon to reduce workforce and operating costs
Sep 26, 2011 10:42 PM |
ENZN
Enzon Q1 net income down
May 09, 2011 09:51 AM |
ENZN
More News on ENZN..
Press Releases
Enzon and Hisun Announce Strategic Alliance for Enzon's Customized PEGylation Linker Technology and Licensing Agreement for PEG-SN38 in China
May 07, 2012 10:04 AM |
ENZN
Enzon Reports First Quarter 2012 Results
May 02, 2012 08:00 AM |
ENZN
Enzon Reports Fourth-Quarter and Full-Year 2011 Results
Mar 12, 2012 08:00 AM |
ENZN
More Press Releases on ENZN..
SEC Filings
Form 4 ENZON PHARMACEUTICALS For: Mar 28 Filed by: Daly Timothy (10K)
Mar 29, 2012 03:56 PM
Form 4 ENZON PHARMACEUTICALS For: Mar 15 Filed by: Young Richard A (10K)
Mar 16, 2012 03:45 PM
Form 3 ENZON PHARMACEUTICALS For: Feb 27 Filed by: HEBARD GEORGE (10K)
Feb 29, 2012 05:53 PM
More SEC Filings on ENZN..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
ENZN
Compare to S&P
YTD
-9.70 %
-19.66 %
4 Weeks
-7.77 %
-6.92 %
12 Weeks
-19.23 %
-20.28 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
71.43 %
EPS Growth in Last Year:
71.43 %
Sales Growth in Last Quarter:
5.89 %
Sales Growth in Last Quarter:
-41.18 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##